Nanopath is a biotechnology and diagnostics company developing rapid molecular testing systems, with an emphasis on decentralized point-of-care testing. Its products are intended for healthcare providers and clinical laboratories, including applications in women’s health and infectious-disease diagnosis.
Subscribe to see Nanopath’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nanopath is a healthtech company. It has raised at least $15M across the 2 funding rounds on record. Its most recent funding round raised $5.3M in January 2025. Xcout tracks 11 named people at Nanopath, including Amogha Tadimety (Co-Chief Executive Officer). Xcout recorded 12 job postings from Nanopath in the last 90 days.
5 more named people on record for Nanopath, with roles, board committees and tenure — see the full roster →
At least $15M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5.3M | — | |
| — | $10M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 12 job postings from Nanopath in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Nanopath's hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.